Advanced Search
Contact | Corporate | Help

Bevacizumab, Erlotinib, and Capecitabine for Locally Advanced Rectal Cancer

Sponsors:
  • M.D. Anderson Cancer Center
  • Genentech
Phases:
  • Phase I
  • Phase II
IndicationsAcronym:
  • Rectal Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Bevacizumab
  • Drug: Capecitabine
  • Drug: Erlotinib
  • Radiation: Radiation Therapy
  • Procedure: Surgery
Enrollment:
52

Additional information about NCT00543842.


SourceSolution © 2008-2012